actelion.comPulmonary Hypertension | Janssen

Sorry, you need to enable JavaScript to visit this website. Skip to main content This section of the global Janssen website provides a company overview in several languages. It is not targeted to any specific audience or country. Click here for country- and region-specific information of interest. Janssen’s COVID-19 Vaccine Status > MENU CLOSE -- JANSSEN GLOBAL CHANGE LOCATION > English Español Français 日本語 Português (Brazil) Italiano 한국어 Русский Search Search Search Our Company About Us Careers Contact Us Grants & Giving Leadership Blogs News Center Our Leaders Patient Safety Information Products Sustainability Transparency Our Focus Therapeutic Areas Cardiovascular, Metabolism & Retina Immunology Infectious Diseases & Vaccines Neuroscience Oncology Global Public Health Patient Engagement Pulmonary Hypertension Our Science Our Response to COVID-19 Clinical Trials Compassionate Use & Pre-Approval Access Janssen Global Trial Finder Research & Development World Without Disease Accelerator Janssen Clinical Innovation Partnerships Precision Medicine and Co-Diagnostics Careers We’re always seeking talented people who share our vision. Click here to explore opportunities in a variety of disciplines across the globe. See More > Leadership Blogs Get to know our leaders. Read their unique perspectives on how they are working to change the trajectory of health. See More > Generation Care™ We’re committed to showing the heart of the caregiver’s experience and providing the kind of support and information that will make a difference. See More > Patient Engagement Janssen partners directly with patients and caregivers as we develop medicines, improve clinical trials, and create educational materials and support programs. See More > Research & Development Our research pipeline is rich with transformational science reflecting our unique approach to innovation. See More > Our Response to COVID-19 Find out how Janssen is committed to supporting patients, healthcare professionals and employees through the COVID-19 pandemic. See More > Collaborating in more than 150 countries. By clicking on a link below, you may enter a different part of this website, or a website outside of Janssen.com. These sections or websites are governed by their own Legal and Privacy Policies. Close Global Janssen Global English | Español Français | Nederlands | -- Português (BR) Italiano | 한국어 РУССКИЙ DEUTSCH -- Asia Pacific Asia Pacific (Regional) English Australia English China 中文 Hong Kong SAR, China English | 中文 India English Japan 日本 Korea 한국어 New Zealand English Europe, Middle East & Africa (EMEA) EMEA (Regional) English Austria Deutsch Belgium English | Français | Nederlands Bulgaria Български Croatia HRVATSKI Czech Republic Čeština Denmark Dansk Egypt English -- Estonia English Finland Suomi France Français Germany Deutsch Greece ΕΛΛΗΝΙΚΑ Hungary Magyar Ireland English Israel עברית Italy Italiano Kazakhstan Русский Latvia English Lithuania English Netherlands Nederlands Norway Norsk Poland Polski Portugal Português Romania Română Russia Русский Serbia SRPSKI Slovakia SLOVENČINA Slovenia Slovenščina South Africa English Spain Español Sweden Svensk Switzerland Deutsch | Français Turkey Türkçe United Kingdom English Latin America Latin America (Regional) ESPAÑOL Argentina Español Bolivia Español Brazil Português Central America and the Caribbean Spanish | English Chile Español Colombia Español Ecuador Español -- Ecuador Español Mexico Español Paraguay Español Peru Español Uruguay Español Venezuela Español -- North America Canada English | Français United States English Home › Pulmonary Hypertension Pulmonary Hypertension Our vision is to transform pulmonary hypertension (PH) into a long-term, manageable condition, so that patients can live a normal life. Read overview Capabilities -- -- -- -- -- Discovery -- -- -- -- -- Development -- -- -- -- -- Commercialization Focus Pulmonary Arterial Hypertension (PAH) Related Stories Five Things We Know about PAH Living with PAH With You Until PH Isn't Partner with Us We are committed to partnering with those who share our vision to transform pulmonary hypertension into a long-term manageable condition. Learn More Leadership We work together to leverage scientific discovery and build on our knowledge to continue to support patients around the world. Learn more Related Links Our Products Contact Pulmonary Hypertension Pulmonary Hypertension Pulmonary Hypertension Normal Artery in Cross Section (Magnification x100) H&E stain Back to Top Find Janssen on: twitter youtube linkedin Find Janssen on: twitter youtube linkedin PRIVACY POLICY LEGAL NOTICE CONTACT US CAREERS NEWS CENTER janssen global © Janssen Global Services, LLC, 2012-2021. All Rights Reserved. Your use of information on this site is subject to the terms of our Legal Notice . Please see our Privacy Policy . This site is published by Janssen Global Services, LLC, which is solely responsible for its contents. Capitalized product names are trademarks of Johnson & Johnson or its affiliated companies. This information is intended for a global audience. Information specific to individual countries is identified where it appears. All third-party trademarks used herein are registered trademarks of their respective owners. Last Updated: May 30, 2021...